BAE Systems Australia will export defence technology designed and developed in Australia to detect and disrupt illicit drugs entering the United States. The company today announced it would deliver a multi-mission digital high frequency (HF) receiver system into the US Government’s Maritime-centric Over the Horizon Radar (MASOR) project which is now a critical part of…
A collaborative project led by hydraulics specialist Hydac Australia has developed a world-first virtual reality product for training maintenance staff, and which will be demonstrated to visitors this week.
Varley Rafael Australia (VRA) is continuing to progress its sovereign guided missile capability and its readiness for local manufacture and support of the Spike LR2 anti-tank and anti-personnel guided missile (pictured). The Spike missile has been selected by the Australian Defence Force and is available in man-portable, vehicle-launched, and helicopter-launched variants. Varley Rafael Australia (VRA)…
Resources and chemicals group Australian Vanadium Limited (AVL) will receive a $49 million grant from the federal government to support a major project in Western Australia to produce critical battery metals and electrolyte for vanadium redox storage batteries. The grant, under the federal government’s Modern Manufacturing Initiative Collaboration Stream, will fund development of the company’s…
University of Wollongong green hydrogen spinout Hysata has published a paper in Nature Communications that it says earns global recognition for their new electrolyser approach, which is “on a clear pathway” to commercialisation and gigawatt-scale production.
The Australian Made Campaign is encouraging consumers to help local businesses fight back across flood devastated Queensland and New South Wales through its new ‘Flood Fightback‘ product page. While rain is finally easing Australian Made is featuring almost 900 businesses across flood-affected communities, providing consumers with a way to discover new and exciting Australian Made…
Medical device innovator Epiminder has raised $18 million in bridging funding to support the development of its lead product Minder, which aims to revolutionise the lives of millions of people suffering from epilepsy and seizures. The raising was supported by existing shareholders Cochlear, the Bionics Institute, the University of Melbourne, Seer Medical and private investors.…
Nuclear science and technology organisation ANSTO has been licensed as the Australian manufacturing partner of a new non-invasive treatment for non-melanoma skin cancer (NMSC). Radioisotope developer OncoBeta and ANSTO will establish local manufacturing of the company’s epidermal radioisotope therapy, Rhenium-SCT (Skin Cancer Therapy) for the treatment of non-melanoma skin cancer. ANSTO operates the OPAL nuclear…
